BASF and Bota Biosciences have officially brought SkinNexus™ Collag3n to market — a 100% human-identical recombinant Collagen III fragment developed through a first-of-its-kind application of Physical AI in cosmetic ingredient discovery. The commercial launch, announced on 30 June 2026, marks the transition of this ingredient from a high-profile trade show introduction to full market availability for personal care formulators…
SkinNexus Collag3n: BASF and Bota Biosciences Complete Market Launch of AI-Designed Bio-Identical Collagen III
Continue reading
Free account required
You're reading Product Innovations. Registration is free and unlocks the full text of this article — and every other non-Premium article.
Sign up for freeAlready have an account? Sign in